Chemical activators of ZFP442 include a diverse array of compounds that influence various signaling pathways leading to its activation. Forskolin stands out as it directly targets adenylate cyclase, resulting in elevated cAMP levels within the cell. The increase in cAMP is a signal for the activation of protein kinase A (PKA), which subsequently phosphorylates ZFP442, thereby activating it. Similarly, IBMX functions by inhibiting phosphodiesterases, enzymes responsible for cAMP degradation, culminating in enhanced action of PKA, which again leads to the phosphorylation and activation of ZFP442. Rolipram and Zaprinast also elevate cellular cAMP levels by specifically inhibiting PDE4 and PDE5, respectively, further amplifying PKA activity and promoting activation of ZFP442 through phosphorylation.
Compounds such as Dibutyryl-cAMP, a cAMP analog, bypass upstream receptors and directly activate PKA, which then targets ZFP442 for phosphorylation and activation. Okadaic Acid, on the other hand, inhibits protein phosphatases that would normally dephosphorylate proteins within the cell, thus potentially maintaining ZFP442 in an active state. Anisomycin acts by stimulating stress-activated protein kinase pathways, which can lead to the direct or indirect phosphorylation of ZFP442. Phorbol Myristate Acetate (PMA) is a potent activator of protein kinase C (PKC), which can phosphorylate a wide range of substrates, including ZFP442, resulting in its activation. Flavopiridol inhibits cyclin-dependent kinases, which could lead to a chain of phosphorylation events culminating in the activation of ZFP442. EGCG and Curcumin can engage PKA or PKC, setting off a phosphorylation cascade that would result in the activation of ZFP442. Lastly, Sodium Orthovanadate acts as a phosphatase inhibitor, preventing the dephosphorylation of proteins and thereby sustaining ZFP442 in an activated state. Each of these chemicals, through their unique mechanisms, ensures the phosphorylation and consequent activation of ZFP442, illustrating the complex interplay of cellular signaling elements in the regulation of protein function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing cAMP breakdown, resulting in PKA activation. PKA phosphorylates and activates ZFP442. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits PDE4, causing an accumulation of cAMP in the cell and subsequent PKA activation, which phosphorylates and activates ZFP442. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast selectively inhibits PDE5, increasing cAMP levels, leading to PKA activation and phosphorylation of ZFP442, resulting in activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, directly activates PKA, which then phosphorylates and activates ZFP442. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases, leading to a sustained phosphorylation state of proteins, which may include ZFP442, thus activating it. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinase pathways, which can lead to the phosphorylation and activation of ZFP442. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which can phosphorylate a range of substrates including ZFP442, leading to its activation. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases, which may affect the phosphorylation and activation of ZFP442. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can activate PKA or PKC through unknown mechanisms, which can phosphorylate and activate ZFP442. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can activate PKA or PKC, which may lead to the phosphorylation and activation of ZFP442. | ||||||